Adalimumab | Humira®, Amgevita (1st line choice... | Moderate to severe Ulcerative Colitis... | 1>5>3 | RED | where conventional therapy... |
Adalimumab | Humira®, Amgevita (1st line choice... | Crohn's disease (NICE TA187) | 1>5>3 | RED | |
Adalimumab | Humira®, Amgevita (1st line choice... | Rheumatic diseases (NICE TA130, 143,... | 10>1>3 | RED | |
Adalimumab | Humira®, Amgevita (1st line choice... | For RA not previously treated with... | 10>1>3 | RED | NICE TAG375 |
Adalimumab | Humira®, Amgevita (1st line choice... | Juvenile idiopathic arthritis - as an... | 10>1>3 | RED | NICE TA373 |
Adalimumab | Humira®, Amgevita (1st line choice... | Rheumatoid arthritis not previously... | 10>1>3 | RED | NICE TA375 |
Adalimumab | Humira®, Amgevita (1st line choice... | Severe plaque psoriasis (NICE TA146) | 13>5>3 | RED | |
Adalimumab | Humira®, Amgevita (1st line choice... | Plaque psoriasis in children and young... | 13>5>3 | RED | NHS England commissioned |
Adalimumab | Humira®, Amgevita (1st line choice... | Non-infectious uveitis as an option by... | 11>4 | RED | NHS England commissioned |
Adalimumab | Humira, Amgevita | Moderate rheumatoid arthritis after... | 10>1>3 | RED | CCG Commissioned [See - 'Rheumatoid... |
Adapalene 0.1%/benzoyl peroxide 2.5% | Epiduo Gel® [0.1% / 2.5%] | Cutaneous treatment of acne vulgaris | 13>6>1 | GREEN | |
Adapalene 0.3%/benzoyl peroxide 2.5% | Epiduo® gel [0.3% / 2.5%] | Cutaneous treatment of acne vulgaris | 13>6>1 | GREEN | |
Adapalene, cream & gel | Differin® | Acne | 13>6>1 | GREEN | |
Adefovir Dipivoxil | Hepsera | Chronic Hepatitis B - NICE TA96 | 5>3>3>1 | RED | Specialist Medicine. NHS England... |
Adenosine | Adenocor® Adenoscan® | Supraventricular arrythmias | 2>3>2 | RED | |
Adrenaline (Epinephrine) 1 in 10,000 | Non-proprietary | Cardiopulmonary resucitation | 2>7>3 | GREEN | |
Adrenaline (Epinephrine) 150mcg &... | Epipen Auto-Injector® Jext®... | Anaphylaxis | 3>4>3 | GREEN | |
Afatinib | | Locally advanced or metastatic squamous... | Black Traffic Light | BLACK | after platinum-based chemotherapy -... |
Afatinib | Giotrif® | epidermal growth factor receptor... | 8>1>5 | RED | recommended as an option NICE TA310 |
Aflibercept | Eylea® | Choroidal neovascularisation in adults | 11>8>2 | RED | NHS England commissioned |